1. ICD-10-CM Codes
›
2. Z00-Z99
›
3. Z77-Z99
›
4. Z85-
›
5. 2023 ICD-10-CM Diagnosis Code Z85

2023 ICD-10-CM Diagnosis Code Z85

Personal history of malignant neoplasm

2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code

• Z85 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
• The 2023 edition of ICD-10-CM Z85 became effective on October 1, 2022.
• This is the American ICD-10-CM version of Z85 - other international versions of ICD-10 Z85 may differ.

• 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
• 2017 (effective 10/1/2016): No change
• 2018 (effective 10/1/2017): No change
• 2019 (effective 10/1/2018): No change
• 2020 (effective 10/1/2019): No change
• 2021 (effective 10/1/2020): No change
• 2022 (effective 10/1/2021): No change
• 2023 (effective 10/1/2022): No change

• Type 2 Excludes: Z86.0
  ICD-10-CM Diagnosis Code Z86.0

  Personal history of in-situ and benign neoplasms and neoplasms of uncertain behavior

  2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code

  Type 2 Excludes

  • personal history of malignant neoplasms (Z85.-)
• Use Additional: Z15.0
  ICD-10-CM Diagnosis Code Z15.0

  Genetic susceptibility to malignant neoplasm

  2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code

  Code First

  • , if applicable, any current malignant neoplasm (C00-C75, C81-C96)

  Use Additional

  • code, if applicable, for any personal history of malignant neoplasm (Z85.-)

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.